Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
Zhen ZhouHong-Sheng ZhangYang LiuZhong-Guo ZhangGuang-Yuan DuHu LiXiao-Ying YuYing-Hui HuangPublished in: Journal of cellular physiology (2017)
Epigenetic modifications such as histone modifications and cytosine hydroxymethylation are linked to tumorigenesis. Loss of 5-hydroxymethylcytosine (5 hmC) by ten-eleven translocation 1 (TET1) down-regulation facilitates tumor initiation and development. However, the mechanisms by which loss of TET1 knockdown promotes malignancy development remains unclear. Here, we report that TET1 knockdown induced epithelial-mesenchymal transition (EMT) and increased cancer cell growth, migration, and invasion in DLD1 cells. Loss of TET1 increased EZH2 expression and reduced UTX-1 expression, thus increasing histone H3K27 tri-methylation causing repression of the target gene E-cadherin. Ectopic expression of the H3K27 demethylase UTX-1 or EZH2 depletion both impeded EZH2 binding caused a loss of H3K27 methylation at epithelial gene E-cadherin promoter, thereby suppressing EMT and tumor invasion in shTET1 cells. Conversely, UTX-1 depletion and ectopic expression of EZH2 enhanced EMT and tumor metastasis in DLD1 cells. These findings provide insight into the regulation of TET1 and E-cadherin and identify EZH2 as a critical mediator of E-cadherin repression and tumor progression.
Keyphrases
- poor prognosis
- epithelial mesenchymal transition
- long non coding rna
- induced apoptosis
- dna methylation
- cell migration
- genome wide
- cell cycle arrest
- signaling pathway
- binding protein
- long noncoding rna
- gene expression
- endoplasmic reticulum stress
- copy number
- transforming growth factor
- oxidative stress
- squamous cell carcinoma
- young adults
- high glucose
- squamous cell